Sofinnova Investments, Inc. Acadia Pharmaceuticals Inc Transaction History

Sofinnova Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$25.02 - $54.99 $4.12 Million - $9.05 Million	-164,625 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $4.75 Million - $6.57 Million	115,629 Added 236.0%	164,625 $8.8 Million
Q3 2020 Nov 13, 2020	BUY	$36.42 - $57.0 $1.78 Million - $2.79 Million	48,996 New	48,996 $2.02 Million
Q3 2019 Nov 14, 2019	SELL	$22.22 - $44.01 $3.46 Million - $6.85 Million	-155,576 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$23.32 - $28.12 $3.63 Million - $4.37 Million	155,576 New	155,576 $4.16 Million

306

157M

828K

317K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.24B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.